FEATURED NEWS

MATEC
September 11, 2015
Today, MATEC launches our new website with a new look and feel. We'll be keeping you current with the latest news and resources on HIV treatment therapies and guidelines. You can continue to register for MATEC programs and learn about our latest projects throughout the region and in each state. If you are looking for upcoming programs, click on your MORE
MATEC
September 11, 2015
Big News, We're Moving! Midwest AIDS Training + Education Center is relocating its Regional Headquarters MORE
MATEC
July 16, 2015
Mr. Gordon Dawson-Tibbits has joined the staff at MATEC's Central Office as the new Business Operations Assistant. In this capacity, Gordon will be assisting in our Business Office with the financial workflow of the Center, and will be ensuring that our office space, and all the resources we have available for our staff, are in working order. He will also MORE
FDA
July 16, 2015
On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults. Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Flu infections can range from mild to severe and can sometimes lead to hospitalization and death. According to the Centers for MORE
ACA
June 10, 2015
The Affordable Care Act made some major changes in the way individuals and families can access health insurance. This bi-weekly update throughout open enrollment is designed to provide information about health care changes for providers. While this is meant to highlight some important changes and updates, it is not an exhaustive list. 1. December 15th MORE
FDA
June 10, 2015
The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. Viekira Pak contains three new drugs-ombitasvir, MORE
FDA
June 10, 2015
On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults. Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Flu infections can range from mild to severe and can sometimes lead to hospitalization and death. According to the Centers for MORE

Pages